These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14719059)

  • 1. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice.
    Kragh M; Hjarnaa PJ; Bramm E; Binderup L
    Oncol Rep; 2004 Feb; 11(2):303-7. PubMed ID: 14719059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity.
    Kragh M; Hjarnaa PJ; Bramm E; Kristjansen PE; Rygaard J; Binderup L
    Int J Oncol; 2003 Feb; 22(2):305-11. PubMed ID: 12527927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
    Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
    Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
    Singh SK; Bhusari S; Singh R; Saxena A; Mondhe D; Qazi GN
    Vascul Pharmacol; 2007 May; 46(5):333-7. PubMed ID: 17257903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of platelet granular mediators in angiogenesis.
    Brill A; Elinav H; Varon D
    Cardiovasc Res; 2004 Aug; 63(2):226-35. PubMed ID: 15249180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
    Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
    Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite its homology to angiostatin apolipoprotein(a) does not affect angiogenesis.
    Lou XJ; Kwan HH; Prionas SD; Yang ZJ; Lawn RM; Fajardo LF
    Exp Mol Pathol; 1998 Oct; 65(2):53-63. PubMed ID: 9828147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.
    Jeon O; Kang SW; Lim HW; Choi D; Kim DI; Lee SH; Chung JH; Kim BS
    Biomaterials; 2006 Mar; 27(8):1617-25. PubMed ID: 16174524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
    Nishikawa T; Akiyama N; Kunimasa K; Oikawa T; Ishizuka M; Tsujimoto M; Natori S
    Eur J Pharmacol; 2006 Jun; 539(3):151-7. PubMed ID: 16725138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.
    Abu-Lila A; Suzuki T; Doi Y; Ishida T; Kiwada H
    J Control Release; 2009 Feb; 134(1):18-25. PubMed ID: 19010364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay.
    Ley CD; Olsen MW; Lund EL; Kristjansen PE
    Microvasc Res; 2004 Nov; 68(3):161-8. PubMed ID: 15501235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.
    Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
    Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
    Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
    Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting.
    Zhu WH; Iurlaro M; MacIntyre A; Fogel E; Nicosia RF
    Angiogenesis; 2003; 6(3):193-9. PubMed ID: 15041795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.
    Michaud-Levesque J; Demeule M; Béliveau R
    Carcinogenesis; 2007 Feb; 28(2):280-8. PubMed ID: 16857721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.